Literature DB >> 23490845

Second-hand tobacco smoke in never smokers is a significant risk factor for coronary artery calcification.

David F Yankelevitz1, Claudia I Henschke, Rowena Yip, Paolo Boffetta, Joseph Shemesh, Matthew D Cham, Jagat Narula, Harvey S Hecht.   

Abstract

OBJECTIVES: The aim of this study was to assess the relationship of the extent of subclinical atherosclerosis measured by coronary artery calcification (CAC) to the extent of second-hand tobacco smoke (SHTS) exposure in asymptomatic people who never smoked.
BACKGROUND: An association between SHTS and CAC was recently reported in a single study, but the quantitative aspects of the relationship are not known.
METHODS: A cohort of 3,098 never smokers 40 to 80 years of age, enrolled in the FAMRI-IELCAP (Flight Attendant Medical Research Institute International Early Lung Cancer Action Program) screening program, completed a SHTS questionnaire, and had a low-dose nongated computed tomography scan. The questionnaire provided a quantitative score for total SHTS exposure, as well as separately as a child and as an adult at home and at work; 4 categories of exposure to SHTS were identified (minimal, low, moderate, and high exposure). CAC was graded using a previously validated ordinal scale score that ranged from 0 to 12. Logistic regression analysis of the prevalence and ordered logistic regression analysis of the extent of CAC were performed to assess the independent contribution of SHTS adjusted for age, sex, diabetes, hypercholesterolemia, hypertension, and renal disease. Linear and quadratic regression analyses of CAC and SHTS were performed.
RESULTS: The prevalence of CAC was 24.3% (n = 754) and was significantly higher in those with more than minimal SHTS exposure compared with those with minimal SHTS exposure (26.4% vs. 18.5%, p < 0.0001). The adjusted odds ratios for CAC prevalence were 1.54 (95% confidence interval: 1.17 to 2.20) for low SHTS exposure, 1.60 (95% confidence interval: 1.21 to 2.10) for moderate exposure, and 1.93 (95% confidence interval: 1.49 to 2.51) for high exposure. The association of the extent of SHTS with the extent of CAC was confirmed by the adjusted odds ratio (p < 0.0001).
CONCLUSIONS: The presence and extent of CAC were associated with extent of SHTS exposure even when adjusted for other risk factors for CAC, suggesting that SHTS exposure causes CAC.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23490845     DOI: 10.1016/j.jcmg.2013.02.004

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  16 in total

1.  Current but not past smoking increases the risk of cardiac events: insights from coronary computed tomographic angiography.

Authors:  Rine Nakanishi; Daniel S Berman; Matthew J Budoff; Heidi Gransar; Stephan Achenbach; Mouaz Al-Mallah; Daniele Andreini; Filippo Cademartiri; Tracy Q Callister; Hyuk-Jae Chang; Victor Y Cheng; Kavitha Chinnaiyan; Benjamin J W Chow; Ricardo Cury; Augustin Delago; Martin Hadamitzky; Jörg Hausleiter; Gudrun Feuchtner; Yong-Jin Kim; Philipp A Kaufmann; Jonathon Leipsic; Fay Y Lin; Erica Maffei; Gianluca Pontone; Gilbert Raff; Leslee J Shaw; Todd C Villines; Allison Dunning; James K Min
Journal:  Eur Heart J       Date:  2015-02-08       Impact factor: 29.983

Review 2.  A clinician's guide to the ABCs of cardiovascular disease prevention: the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease and American College of Cardiology Cardiosource Approach to the Million Hearts Initiative.

Authors:  Steven Hsu; Van-Khue Ton; M Dominique Ashen; Seth S Martin; Ty J Gluckman; Payal Kohli; Stephen D Sisson; Roger S Blumenthal; Michael J Blaha
Journal:  Clin Cardiol       Date:  2013-05-13       Impact factor: 2.882

3.  Passive smoke exposure and risk of diabetes: a meta-analysis of prospective studies.

Authors:  Kan Sun; Dan Liu; Chuan Wang; Men Ren; Chuan Yang; Li Yan
Journal:  Endocrine       Date:  2014-02-16       Impact factor: 3.633

4.  Lung Cancer Workshop XI: Tobacco-Induced Disease: Advances in Policy, Early Detection and Management.

Authors:  James L Mulshine; Rick Avila; David Yankelevitz; Thomas M Baer; Raul San Jose Estépar; Laurie Fenton Ambrose; Carolyn R Aldigé
Journal:  J Thorac Oncol       Date:  2015-05       Impact factor: 15.609

Review 5.  Role of chest computed tomography in prevention of occupational respiratory disease: review of recent literature.

Authors:  David N Weissman
Journal:  Semin Respir Crit Care Med       Date:  2015-05-29       Impact factor: 3.119

Review 6.  The importance of the regimen of screening in maximizing the benefit and minimizing the harms.

Authors:  Claudia I Henschke; Kunwei Li; Rowena Yip; Mary Salvatore; David F Yankelevitz
Journal:  Ann Transl Med       Date:  2016-04

7.  Cigarette Smoke Extract Activates Tartrate-Resistant Acid Phosphatase-Positive Macrophage.

Authors:  Kimihiro Igari; Matthew J Kelly; Dai Yamanouchi
Journal:  J Vasc Res       Date:  2019-05-07       Impact factor: 1.934

8.  Remote exposure to secondhand tobacco smoke is associated with lower exercise capacity through effects on oxygen pulse, a proxy of cardiac stroke volume.

Authors:  Siyang Zeng; Michelle Dunn; Warren M Gold; Jorge R Kizer; Mehrdad Arjomandi
Journal:  BMJ Open Respir Res       Date:  2022-05

Review 9.  Clinician's guide to the updated ABCs of cardiovascular disease prevention.

Authors:  Payal Kohli; Seamus P Whelton; Steven Hsu; Clyde W Yancy; Neil J Stone; Jonathan Chrispin; Nisha A Gilotra; Brian Houston; M Dominique Ashen; Seth S Martin; Parag H Joshi; John W McEvoy; Ty J Gluckman; Erin D Michos; Michael J Blaha; Roger S Blumenthal
Journal:  J Am Heart Assoc       Date:  2014-09-22       Impact factor: 5.501

Review 10.  Particulate matter and atherosclerosis: a bibliometric analysis of original research articles published in 1973-2014.

Authors:  Feifei Wang; Xiaofeng Jia; Xianliang Wang; Yongdong Zhao; Weidong Hao
Journal:  BMC Public Health       Date:  2016-04-19       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.